Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort

Human Immunology

Volumn 70, Issue 6, 2009, Pages 440-446

  Petermann, Ivonne ^a,c   Huebner, Claudia ^a,c   Browning, Brian L ^a,c   Gearry, Richard B ^b   Barclay, Murray L ^b   Kennedy, Martin ^b   Roberts, Rebecca ^b   Shelling, Andrew N ^a,c   Philpott, Martin ^a,c   Han, Dug Yeo ^a,c   Ferguson, Lynnette R ^a,c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

^c Nutrigenomics New Zealand   (New Zealand)

Author keywords

Bactericidal permeability increasing protein (BPI); Caspase recruitment domain containing protein 15 (CARD15); Inflammatory bowel disease (IBD); Monocyte differentiation antigen CD14 (CD14); Toll like receptor 4 (TLR4)

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; TOLL LIKE RECEPTOR 9;

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; COLON CROHN DISEASE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENE MAPPING; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFANT; INFECTION RISK; MALE; NEW ZEALAND; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; ANTIGENS, CD14; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATORY BOWEL DISEASES; MALE; NEW ZEALAND; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 9; YOUNG ADULT;

EID: 67349244353     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.03.002     Document Type: Article

References (54)

1. Tobias P.S., Gegner J., Tapping R., Orr S., Mathison J., et al. Lipopolysaccharide dependent cellular activation. J Periodont Res 32 (1997) 99
2. Ulevitch R.J., and Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13 (1995) 437
3. Pastor Rojo O., Lopez San Roman A., Albeniz Arbizu E., de la Hera Martinez A., Ripoll Sevillano E., and Albillos Martinez A. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm Bowel Dis 13 (2007) 269-277
4. Bonen D.K., Ogura Y., Nicolae D.L., Inohara N., Saab L., Tanabe T., et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 124 (2003) 140
5. Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D., Mathison J.C., et al. Structure and function of lipopolysaccharide binding protein. Science 249 (1990) 1429
6. Tobias P.S., Mathison J., Mintz D., Lee J.D., Kravchenko V., Kato K., et al. Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation. Am J Respir Cell Mol Biol 7 (1992) 239
7. Bazil V., Horejsi V., Baudys M., Kristofova H., Strominger J.L., Kostka W., and Hilgert I. Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur J Immunol 16 (1986) 1583
8. Goyert S.M., Ferrero E., Rettig W.J., Yenamandra A.K., Obata F., and Le Beau M.M. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 239 (1988) 497
9. da Silva Correia J., Soldau K., Christen U., Tobias P.S., and Ulevitch R.J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer from CD14 to TLR4 and MD-2. J Biol Chem 276 (2001) 21129
10. Jiang Q., Akashi S., Miyake K., and Petty H.R. Lipopolysaccharide induces physical proximity between CD14 and Toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. J Immunol 165 (2000) 3541
11. Elsbach P. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukoc Biol 64 (1998) 14
12. Elsbach P., and Weiss J. Role of the bactericidal/permeability-increasing protein in host defence. Curr Opin Immunol 10 (1998) 45
13. Weiss J. Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): Structure, function and regulation in host defence against Gram-negative bacteria. Biochem Soc Trans 31 (2003) 785
14. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25 (2000) 187
15. Arnott I.D., Nimmo E.R., Drummond H.E., Fennell J., Smith B.R., MacKinlay E., et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: Evidence for genetic heterogeneity within Europe?. Genes Immun 5 (2004) 417
16. Bieli C., Eder W., Frei R., Braun-Fahrlander C., Klimecki W., Waser M., et al., Parsifal Study Team. A polymorphism in CD14 modifies the effect of farm milk consumption on allergic diseases and CD14 gene expression. J Allergy Clin Immunol 120 (2007) 1308-1315
17. Browning B.L., Huebner C., Petermann I., Gearry R.B., Barclay M.L., Shelling A.N., Ferguson L.R., et al. Has Toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene?. Association study combined with meta-analysis shows strong evidence for association. Am J Gastroenterol 102 (2007) 2504-2512
18. Franchimont D., Vermeire S., El Housni H., Pierik M., Van Steen K., Gustot T., et al. Deficient host-bacteria interactions in inflammatory bowel disease?. The Toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53 (2004) 987
19. Gazouli M., Mantzaris G., Kotsinas A., Zacharatos P., Papalambros E., Archimandritis A., et al. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 11 (2005) 681
20. Lammers K.M., Ouburg S., Morre S.A., Crusius J.B., Gionchett P., Rizzello F., et al. Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis. World J Gastroenterol 11 (2005) 7323
21. Roberts R.L., Gearry R.B., Hollis-Moffatt J.E., Miller A.L., Reid J., Abkevich V., et al. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Am J Gastroenterol 102 (2007) 2754-2761
22. Girardin S.E., Hugot J.P., and Sansonetti P.J. Lessons from Nod2 studies: Towards a link between Crohn's disease and bacterial sensing. Trends Immunol 24 (2003) 652
23. Inohara N., and Nunez G. The NOD: A signaling module that regulates apoptosis and host defense against pathogens. Oncogene 20 (2001) 6473
24. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 278 (2003) 5509
25. Annese V., Lombardi G., Perri F., D'Inca R., Ardizzone S., Riegler G., et al. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease-an IG-IBD study. Am J Gastroenterol 100 (2005) 84
26. Bairead E., Harmon D.L., Curtis A.M., Kelly Y., O'Leary C., Gardner M., et al. Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur J Hum Genet 11 (2003) 237
27. Economou M., Trikalinos T.A., Loizou K.T., Tsianos E.V., and Ioannidis J.P. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: A metaanalysis. Am J Gastroenterol 99 (2004) 2393
28. Giachino D., van Duist M.M., Regazzoni S., Gregori D., Bardessono M., Salacone P., et al. Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients. Eur J Hum Genet 12 (2004) 206
29. Lakatos P.L., Lakatos L., Szalay F., Willheim-Polli C., Osterreicher C., Tulassay Z., et al. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: Phenotype-genotype correlations. World J Gastroenterol 11 (2005) 1489
30. Torkvist L., Noble C.L., Lordal M., Sjoqvist U., Lindforss U., Nimmo E.R., et al. Contribution of CARD15 variants in determining susceptibility to Crohn's disease in Sweden. Scand J Gastroenterol 41 (2006) 700
31. Vind I., Vieira A., Hougs L., Tavares L., Riis L., Andersen P.S., et al. NOD2/CARD15 gene polymorphisms in Crohn's disease: A genotype-phenotype analysis in Danish and Portuguese patients and controls. Digestion 72 (2005) 156
32. Gearry R.B., Roberts R.L., Burt M.J., Frampton C.M., Chapman B.A., Collett J.A., et al. Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort. Inflamm Bowel Dis 13 (2007) 1220
33. Gearry R.B., Richardson A., Frampton C.M., Collett J.A., Burt M.J., Chapman B.A., and Barclay M.L. High incidence of Crohn's disease in Canterbury, New Zealand: Results of an epidemiologic study. Inflamm Bowel Dis 12 (2006) 936
34. Hubacek J.A., Rothe G., Pit'ha J., Skodova Z., Stanek V., Poledne R., and Schmitz G. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99 (1999) 3218
35. Unkelbach K., Gardemann A., Kostrzewa M., Philipp M., Tillmanns H., and Haberbosch W. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol 19 (1999) 932
36. Klein W., Tromm A., Griga T., Fricke H., Folwaczny C., Hocke M., et al. A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol 37 (2002) 189
37. Obana N., Takahashi S., Kinouchi Y., Negoro K., Takagi S., Hiwatashi N., and Shimosegawa T. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand J Gastroenterol 37 (2002) 699
38. Vainas T., Stassen F.R., Bruggeman C.A., Welten R.J., van den Akker L.H., Kitslaar P.J., et al. Synergistic effect of Toll-like receptor 4 and CD14 polymorphisms on the total atherosclerosis burden in patients with peripheral arterial disease. J Vasc Surg 44 (2006) 326
39. Klein W., Tromm A., Folwaczny C., Hagedorn M., Duerig N., Epplen J., et al. A polymorphism of the bactericidal/permeability increasing protein (BPI) gene is associated with Crohn's disease. J Clin Gastroenterol 39 (2005) 282
40. Torok H.P., Glas J., Tonenchi L., Bruennler G., Folwaczny M., and Folwaczny C. Crohn's disease is associated with a Toll-like receptor-9 polymorphism. Gastroenterology 127 (2004) 365
41. Burt M.J., George P.M., Upton J.D., Collett J.A., Frampton C.M., Chapman T.M., et al. The significance of haemochromatosis gene mutations in the general population: Implications for screening. Gut 43 (1998) 830
42. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol 170 (1989) 2-6
43. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19 Suppl A (2005) 5-36
44. Leushner J., and Chiu N.H. Automated mass spectrometry: A revolutionary technology for clinical diagnostics. Mol Diagn 5 (2000) 341
45. Sasieni P.D. From genotypes to genes: Doubling the sample size. Biometrics 53 (1997) 1253
46. Wigginton J.E., Cutler D.J., and Abecasis G.R. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 76 (2005) 887
47. Ihaka R.G. R: A language for data analysis and graphics. J Computat Graph Stat 5 (1996) 299-314
48. Shi Y.Y., and He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15 (2005) 97
49. Khoury M.J., and Flanders W.D. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: Case-control studies with no controls!. Am J Epidemiol 144 (1996) 207
50. Cordell H.J. Epistasis: What it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet 11 (2002) 2463
51. Canny G., and Colgan S.P. Events at the host-microbial interface of the gastrointestinal tract. I. Adaptation to a microbial world: Role of epithelial bactericidal/permeability-increasing protein. Am J Physiol Gastrointest Liver Physiol 288 (2005) G593
52. Monajemi H., Meenan J., Lamping R., Obradov D.O., Radema S.A., Trown P.W., et al. Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein. Gastroenterology 110 (1996) 733
53. Klein W., Tromm A., Griga T., Folwaczny C., Hocke M., Eitner K., et al. Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease. Scand J Gastroenterol 38 (2003) 834
54. Torok H.P., Glas J., Tonenchi L., Mussack T., and Folwaczny C. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: Association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol 112 (2004) 85